NEWSROOM

Press Releases

In the News

Logo & Resources Library

Recent News

Potential New Treatment in Phase III Trial

New York, NY, October 16, 2019 — The Lupus Research Alliance is excited to announce that a potential new medicine...

Welcoming Daniel J. Wallace, MD to Lupus Therapeutics

New York, NY, October 16, 2019 — The Lupus Research Alliance (LRA) affiliate Lupus Therapeutics is pleased to announce that Daniel...

Peer-to-Peer Involvement Advances Scientific Exploration

New York, NY, October 16, 2019 — Many dynamics of lupus contribute to the fact that its complexities have eluded...

Lupus Therapeutics Shifting the Paradigm

New York, NY, October 16, 2019 — The Lupus Research Alliance (LRA)—going bold and thinking big—has once again shifted the...

10 Lupus Therapeutics Studies Currently Underway

New York, NY, October 6, 2019 — TAK-079A Study to Evaluate the Safety of TAK-079 PAISLEY-SLEA Phase II study to evaluate a...

Dr. Daniel Wallace Appointed to Lupus Therapeutics Board

New York, NY, July 18, 2019 — The Lupus Research Alliance (LRA) affiliate Lupus Therapeutics is pleased to announce that Daniel Wallace,...

Lupus Therapeutics Expands Collaboration with Bristol-Myers Squibb to Test Potential Treatment for Lupus

New York, NY, June 27, 2019 — The Lupus Research Alliance (LRA) and its affiliate, Lupus Therapeutics, announced that...

Lupus Research Alliance and Lupus Therapeutics – Leading Voices in Trial Diversity

New York, NY, June 25, 2019 — Caroline Donovan, Manager of Patient Engagement at Lupus Research Alliance (LRA) affiliate Lupus...

VALUE Study Results Reported at EULAR

Madrid, Spain, June 13, 2019 — Results of the first clinical trial sponsored by the Lupus Research Alliance and conducted...

Taking Scientific Discovery: From Lab Bench to You

New York, NY, April 8, 2019 — Making new and efficacious lupus therapies available to patients has long been a major...

Lupus Therapeutics Partners with Takeda to Test Potential Treatment for Lupus

New York, NY, March 1, 2019 — The Lupus Research Alliance and its affiliate, Lupus Therapeutics announced a collaboration...

Lupus Therapeutics Launches Peer Training Program to Help Patients Benefit from Clinical Trials

New York, NY, February 1, 2019 — Today, Lupus Therapeutics, an affiliate of Lupus Research Alliance, is launching our Patient Advocates...